Maier Marissa M, Ross David B, Chartier Maggie, Belperio Pamela S, Backus Lisa I
Marissa M. Maier is with the VA Portland Health Care System, Veterans Health Administration (VHA), Portland, OR, and the Office of Public Health/HIV, Hepatitis, and Public Health Pathogens Programs, VHA, Washington, DC. David B. Ross is with the VA Washington DC Health Care System, and the Office of Public Health/HIV, Hepatitis, and Public Health Pathogens Programs, VHA, Washington, DC. Maggie Chartier is with the VA San Francisco Health Care System, VHA, San Francisco, CA, and the Office of Public Health/HIV, Hepatitis, and Public Health Pathogens Programs, VHA, Washington, DC. Pamela S. Belperio is with the VA Greater Los Angeles Health Care System, VHA, Los Angeles, CA, and the Office of Public Health/Population Health, VHA, Washington, DC. Lisa I. Backus is with the VA Palo Alto Health Care System, VHA, Palo Alto, CA, and the Office of Public Health/Population Health, VHA, Washington, DC.
Am J Public Health. 2016 Feb;106(2):353-8. doi: 10.2105/AJPH.2015.302927. Epub 2015 Nov 12.
We measured the quality of HCV care using a cascade of HCV care model.
We estimated the number of patients diagnosed with chronic HCV, linked to HCV care, treated with HCV antivirals, and having achieved a sustained virologic response (SVR) in the electronic medical record data from the Veterans Health Administration's Corporate Data Warehouse and the HCV Clinical Case Registry in 2013.
Of the estimated 233,898 patients with chronic HCV, 77% (181,168) were diagnosed, 69% (160,794) were linked to HCV care, 17% (39,388) were treated with HCV antivirals, and 7% (15,983) had achieved SVR.
This Cascade of HCV Care provides a clinically relevant model to measure the quality of HCV care within a health care system and to compare HCV care across health systems.
我们使用丙型肝炎病毒（HCV）治疗级联模型来衡量HCV治疗质量。
我们从退伍军人健康管理局的企业数据仓库和2013年的HCV临床病例登记处的电子病历数据中，估算出被诊断为慢性HCV、接受HCV治疗、接受HCV抗病毒治疗并实现病毒学持续应答（SVR）的患者数量。
在估计的233,898例慢性HCV患者中，77%（181,168例）被诊断出来，69%（160,794例）接受了HCV治疗，17%（39,388例）接受了HCV抗病毒治疗，7%（15,983例）实现了SVR。
这种HCV治疗级联提供了一个临床相关模型，用于衡量医疗保健系统内HCV治疗的质量，并比较不同医疗系统之间的HCV治疗情况。
